Jl. Neisewander et al., EFFECTS OF SCH-23390 ON DOPAMINE D1 RECEPTOR OCCUPANCY AND LOCOMOTIONPRODUCED BY INTRAACCUMBENS COCAINE INFUSION, Synapse, 30(2), 1998, pp. 194-204
This study examined the effects of both systemic and intraaccumbens ad
ministration of SCH-23390 in rats on dopamine D1 receptor occupancy an
d on locomotor activity produced by intraaccumbens infusion of cocaine
. In experiment 1, rats received SCH-23390 (0-1 mg/kg, IP) 15 minutes
prior to intraaccumbens infusion of cocaine (0 or 100 mu g/side). In e
xperiment 2, rats received coinfusion of SCH-23390 (0-1 mu g/side) and
cocaine (0 or 100 mu g/side) into the nucleus accumbens (NAc). After
behavioral testing, receptors occupied by SCH-23390 were quantified by
injecting animals with their respective dose of SCH-23390, followed b
y a systemic injection of the irreversible antagonist N-ethoxycarbonyl
-2-ethoxy-1,2-dihydroquinoline (EEDQ). Receptors occupied by SCH-23390
, and therefore protected from EEDQ-induced inactivation: were quantif
ied from autoradiograms of sections labeled with H-3-SCH-23390. System
ic administration of SCH-23390 dose-dependently (0.1-1.0 mg/kg) revers
ed cocaine-induced locomotion and occupied 72-100% of D1-like receptor
s in the anterior NAc. D1 receptor occupancy following systemic admini
stration of SCH-23390 was evident as an inverted U-shaped, dose-depend
ent change, with the greatest occupancy observed at the intermediate d
ose of 0.3 mg/kg. Intraaccumbens infusion of SCH-23390 did not alter c
ocaine-induced locomotor activity despite occupying 40-60% of D1-like
receptors in the anterior NAc core and shell. The findings that system
ic, but not intraaccumbens, administration of SCH-23390 potently rever
sed locomotion produced by intraaccumbens cocaine infusion suggest tha
t stimulation of D1 receptors in regions other than the NAc is involve
d in locomotion produced by intraaccumbens infusion of cocaine, and th
at stimulation of D1 receptors in the NAc is not necessary for this be
havior Synapse 30:194-204, 1998. (C) 1998 Wiley-Liss, Inc.